Page last updated: 2024-10-28

hydrochlorothiazide and Cardiac Arrest, Sudden

hydrochlorothiazide has been researched along with Cardiac Arrest, Sudden in 2 studies

Hydrochlorothiazide: A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.
hydrochlorothiazide : A benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure.

Research Excerpts

ExcerptRelevanceReference
"Hypertension is one of the most common cardiovascular risk factors."2.73[Intensive blood pressure reduction in patients with increased cardiovascular risk with high-dose combination therapy of 160 mg valsartan plus 25 mg hydrochlorothiazide. Results of the MACHT II observational study]. ( Abts, M; Kastrati, D; Schühlen, H, 2007)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ong, HT1
Schühlen, H1
Abts, M1
Kastrati, D1

Trials

1 trial available for hydrochlorothiazide and Cardiac Arrest, Sudden

ArticleYear
[Intensive blood pressure reduction in patients with increased cardiovascular risk with high-dose combination therapy of 160 mg valsartan plus 25 mg hydrochlorothiazide. Results of the MACHT II observational study].
    Herz, 2007, Volume: 32, Issue:5

    Topics: Antihypertensive Agents; Death, Sudden, Cardiac; Drug Administration Schedule; Drug Therapy, Combina

2007

Other Studies

1 other study available for hydrochlorothiazide and Cardiac Arrest, Sudden

ArticleYear
LIFE: losartan versus atenolol.
    Lancet (London, England), 2003, Oct-25, Volume: 362, Issue:9393

    Topics: Antihypertensive Agents; Atenolol; Comorbidity; Death, Sudden, Cardiac; Diabetes Mellitus; Drug Ther

2003